Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) shares dropped 2.8% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $46.15 and last traded at $46.15. Approximately 11,645 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 111,924 shares. The stock had previously closed at $47.49.
Specifically, Director John Kenneth Paglia sold 1,200 shares of the company’s stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $46.45, for a total transaction of $55,740.00. Following the completion of the transaction, the director now directly owns 2,644 shares of the company’s stock, valued at $122,813.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Walter S. Woltosz sold 16,246 shares of the company’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $43.07, for a total transaction of $699,715.22. Following the sale, the director now owns 3,840,212 shares in the company, valued at $165,397,930.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Kenneth Paglia sold 1,200 shares of the company’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $46.45, for a total value of $55,740.00. Following the completion of the sale, the director now owns 2,644 shares in the company, valued at approximately $122,813.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 57,446 shares of company stock valued at $2,506,855. Company insiders own 21.30% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. StockNews.com assumed coverage on Simulations Plus in a research report on Thursday, May 18th. They issued a “hold” rating on the stock. Oppenheimer reaffirmed an “outperform” rating and set a $65.00 target price on shares of Simulations Plus in a research report on Thursday, April 6th. Finally, BTIG Research started coverage on Simulations Plus in a research report on Tuesday, May 9th. They issued a “buy” rating and a $55.00 price objective for the company. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.50.
Simulations Plus Stock Performance
Simulations Plus (NASDAQ:SLP – Get Free Report) last issued its quarterly earnings data on Thursday, July 6th. The technology company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.01). Simulations Plus had a net margin of 18.74% and a return on equity of 6.20%. The firm had revenue of $16.23 million for the quarter, compared to the consensus estimate of $16.09 million. During the same period last year, the company posted $0.20 earnings per share. As a group, equities research analysts predict that Simulations Plus, Inc. will post 0.64 earnings per share for the current year.
Simulations Plus Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, August 7th. Investors of record on Monday, July 31st will be paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date is Friday, July 28th. Simulations Plus’s payout ratio is currently 47.06%.
Hedge Funds Weigh In On Simulations Plus
A number of institutional investors have recently bought and sold shares of the stock. US Bancorp DE grew its holdings in Simulations Plus by 62.9% in the first quarter. US Bancorp DE now owns 668 shares of the technology company’s stock worth $29,000 after purchasing an additional 258 shares during the period. Point72 Middle East FZE bought a new position in Simulations Plus in the 4th quarter valued at approximately $35,000. Tower Research Capital LLC TRC boosted its stake in Simulations Plus by 82.2% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,421 shares of the technology company’s stock valued at $69,000 after purchasing an additional 641 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of Simulations Plus in the 4th quarter worth $61,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Simulations Plus by 17.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,730 shares of the technology company’s stock valued at $76,000 after purchasing an additional 252 shares in the last quarter. 74.22% of the stock is owned by institutional investors.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles
- Five stocks we like better than Simulations Plus
- Green Hydrogen Stocks Getting Ready to Deliver Big Gains
- Charles Schwab Gets The Rebound, Time to Buy?
- Is Ebix Inc a Phygital E-Commerce Contender or Pretender?
- 3 Mid-Cap Stocks with Expectations for High-Earnings Growth
- Can Lockheed Martin Fly To A New High In 2023?
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
